z-logo
open-access-imgOpen Access
Controlled Trials of Amphotericin B Lipid Complex and Other Lipid-Associated Formulations
Author(s) -
D. J. Winston,
Gary J. Schiller
Publication year - 2000
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/313579
Subject(s) - medicine , amphotericin b , lipid profile , pharmacology , cholesterol , antifungal , dermatology
are indicated to determine the true incidence of melioidosis in Central America, South America, and the Caribbean. Finally, I must correct some factual inaccuracies. First, the patient originally described by Whitmore and Krishnaswami [7] was 40 years old, not 10 years old as stated by Dorman et al. [1]. Second, the longest incubation period for melioidosis has recently been increased to 29 years [8]. Last, the case reported by Lee et al. [2] is not, as they state, the first reported case of mycotic aneurysm caused by B. pseudomallei; an earlier case was reported in 1996 [9].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom